Harrow Health (HROWL) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 0 251 sessions, October 10, 2024 to October 10, 2025
- Largest daily move
- -1.9% close of July 15, 2025
- 1-year change
- +0% closing prices, October 10, 2024 to October 10, 2025
- 1-month change
- -0.1% closing prices, September 10, 2025 to October 10, 2025
Company Description
HROWL gained 0.0% in the 12 months to October 10, 2025. The last closing price was $25.61.
For FY2025, Harrow Health reported revenue of $272.3M with net income of -$5.1M and diluted earnings per share of -$0.14. The company operates at a net profit margin of -1.9%.
This page collects what Stock Titan holds for HROWL, including price data, SEC filings, and financial highlights.
Stock Performance
Harrow Health (HROWL) closed at $25.61 on October 10, 2025. In the 12 months to October 10, 2025, the price gained 0.0%.
HROWL Metrics & Rankings
Price returns through October 10, 2025. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
Harrow Health has filed 10 recent SEC filings, including 5 Form 4, 2 Form 8-K, 1 Form 10-Q, 1 Form SCHEDULE 13G/A. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all HROWL SEC filings →
Financial Highlights
Harrow Health generated $272.3M in revenue in FY2025, retaining a 75.0% gross margin, operating income reached $30.5M (11.2% operating margin), and net income was -$5.1M, reflecting a -1.9% net profit margin. Diluted earnings per share stood at -$0.14. The company generated $43.9M in operating cash flow. The current ratio was 2.20, measuring current assets divided by current liabilities.